Chemoradiotherapy After Surgery Versus Preoperative Chemoradiotherapy for Stage II/III Mid-low Rectal Cancer With or Without High-risk Factors
NCT06566222 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2024-08-22
Summary
The purpose of this observational study is to understand the effect of different timing of chemoradiotherapy on overall survival in patients with stage II/III low- and medium-level rectal cancer with or without high-risk factors
Conditions
- Radiotherapy
Interventions
- PROCEDURE
-
chemoradiotherapy after surgery
chemoradiotherapy after surgery vs preoperative chemoradiotherapy
- OTHER
-
High-risk Factors
High-risk Factors vs low-risk Factors
Sponsors & Collaborators
-
Changhai Hospital
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-08-25
- Primary Completion
- 2024-09-30
- Completion
- 2024-12-31
More Related Trials
-
Tumor Local Excision +Postoperative Adjuvant Chemoradiotherapy for T1-2N0M0 Low/Ultra-Low Rectal Cancer
NCT06949098 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Postoperative Concurrent Chemo-radiation With Capecitabine in Elderly Rectal Cancer Patients
NCT01268943 ·Status: COMPLETED ·Phase: PHASE1
-
Short-course Preoperative Chemoradiotherapy Followed by Delayed Operation for Locally Advanced Rectal Cancer
NCT01129700 ·Status: COMPLETED ·Phase: PHASE2
-
Organ Preservation Strategy of Total Neoadjuvant Chemoradiotherapy for Low Rectal Carcinoma
NCT05563922 ·Status: RECRUITING ·Phase: PHASE2
-
Randomized Controlled Study on Optimize Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
NCT02031939 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk
NCT04664504 ·Status: RECRUITING ·Phase: PHASE2
-
Multicenter, Prospective, RCT:Investigation of Combined Modality Therapy for Locally Advanced Mid/Low Rectal Cancer.
NCT03042000 ·Status: UNKNOWN ·Phase: NA
-
Additional Chemotherapy After Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer
NCT01671683 ·Status: COMPLETED
-
Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks
NCT01037049 ·Status: UNKNOWN ·Phase: PHASE2
-
Preoperative Chemoradiotherapy With Cetuximab in Rectal Cancer
NCT00506844 ·Status: UNKNOWN ·Phase: PHASE2
-
High Dose Radiotherapy for the Treatment of Rectal Cancer
NCT03541304 ·Status: COMPLETED
-
Oncologic Risk of Rectal Preservation Against Medical Advice After Chemoradiotherapy for Rectal Cancer
NCT03923309 ·Status: COMPLETED
-
Preoperative CRT With Temozolomide Plus Capecitabine in Rectal Cancer
NCT01781403 ·Status: COMPLETED ·Phase: PHASE1
-
Response-adapted Total Neoadjuvant Therapy Guided by Induction Chemotherapy in Early- and Intermediate-risk Low Rectal Cancer for Implementation of a Watch-and-wait Strategy
NCT07260526 ·Status: RECRUITING
-
A Prospective Phase II Randomized Clinical Trial of Preoperative Chemotherapy Combined With Short-course Radiotherapy Versus Conventional Neo-adjuvant Therapy for Locally Advanced Rectal Cancer Implemented by MDT
NCT02941562 ·Status: UNKNOWN ·Phase: PHASE2
-
Preoperative Intraarterial Chemoembolization Combined With Radiotherpy in Locally Advanced Rectal Cancer
NCT03601156 ·Status: UNKNOWN ·Phase: NA
-
Outcomes of Neoadjuvant Therapy for Rectal Cancer in a Tertiary Asian Institute
NCT05607186 ·Status: COMPLETED
-
Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal Cancer
NCT03573791 ·Status: RECRUITING
-
Proximally Extended Resection for Rectal Cancer After Neoadjuvant Chemoradiotherapy
NCT02649647 ·Status: RECRUITING ·Phase: NA
-
Genetic Profile on Predicting Sensibility of Preoperative Chemoradiotherapy on Locally Advanced Rectal Carcinoma
NCT01930942 ·Status: UNKNOWN ·Phase: PHASE2
-
Preoperative Chemoradiotherapy With Raltitrexed for Intermediate or Locally Advanced Rectal Cancer in the Fit Elderly
NCT02992886 ·Status: COMPLETED ·Phase: PHASE2
-
Effective Study of Preoperative Short-course Radiotherapy for the Advanced Resectable Rectal Cancer
NCT01437514 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Preoperative CRT With Capecitabine ± Temozolomide in Patients With LARC
NCT03156036 ·Status: COMPLETED ·Phase: PHASE2
-
Radical vs Local Excision for Rectal Cancer With Clinically Complete Remission
NCT05964530 ·Status: RECRUITING ·Phase: NA
-
Predicting the Efficacy and Prognosis of Rectal Cancer Patients Based on ctDNA-MRD Technology
NCT05969938 ·Status: UNKNOWN